Original Article
Author Details :
Volume : 5, Issue : 1, Year : 2019
Article Page : 52-56
https://doi.org/10.18231/2581-4761.2019.0012
Abstract
Broad-spectrum beta lactam antibiotics are the most commonly used antibiotics in the clinical setting. Resistance to these beta lactam antibiotics mediated by extended spectrum beta lactamases (ESBLs), AmpC beta lactamases and Metallo beta lactamases (MBLs) enzymes is an increasing common public health problem. Determination of their prevalence is essential for epidemiological purpose and to formulate an effective antibiotic policy to avoid treatment failure.
A total of 934 clinical isolates comprising of Escherichia coli, Klebsiella pneumoniae, Proteus spp. And A cinetobacter baumannii, which were recovered from various clinical specimens over a period of a year i.e., from January 2017 to December 2017, were studied. Antibiogram profile was determined by Kirby-Bauer disc diffusion method and was interpreted by using CLSI guidelines. Detection of ESBL was done using ceftazidime and ceftazidime-clavulanic acid combination discs method, AmpC producers were detected by AmpC disc test and MBL production was done using Imipenem-EDTA combined disc test.
Among 934 isolates 246(26.3%) strains were ESBL producers, 91(9.7%) AmpC producers and 143(15.3%) were MBL producers. The co-production of ESBL/AmpC/MBL beta lactamases was observed in 160(17.1%).
The study emphasizes the need for the early detection of isolates that produce these enzymes to avoid therapeutic failures and nosocomial outbreaks.
Keywords: Extended spectrum beta-lactamases, AmpC beta-lactamases, Metallo beta-lactamases, Prevalence, Co-production.
How to cite : Chanu T R, Shah P K, Soni S, Ghosh A, Phenotypic detection of extended spectrum, AmpC, Metallo beta-lactamases and their coexistence in clinical isolates of commonly isolated gram negativebacteria in GKGH hospital, Bhuj. IP Int J Med Microbiol Trop Dis 2019;5(1):52-56
This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
Viewed: 3181
PDF Downloaded: 627